Markets
Tendies
@tendies
Bought EYEN
Shares
up 4197%
At 0.87, Exited 37.2
EYEN is incredibly undervalued and with their FDA-approved products and multiple partnerships, I believe this stock is poised for significant gains. A...
Read
More
Thesis
EYEN is incredibly undervalued and with their FDA-approved products and multiple partnerships, I believe this stock is poised for significant gains. Analysts predict it could reach $8 this year, so it's a solid long-term investment opportunity.
Go back
Tendies
@tendies
Bought EYEN
Shares
up 4197%
At 0.87, Exited 37.2
EYEN is currently undervalued and has multiple FDA-approved products. They're releasing second quarter results soon and have big plans for mid-2024. A...
Read
More
Thesis
EYEN is currently undervalued and has multiple FDA-approved products. They're releasing second quarter results soon and have big plans for mid-2024. Analysts predict significant gains. It's a great time to invest in EYEN for long-term gains.
Go back
Tendies
@tendies
Bought CTXR
Shares
up 1104%
At 0.82, Exited 9.88
Citius Pharmaceuticals just received FDA approval for their new immunotherapy treatment, LYMPHIR. This approval could lead to significant revenue grow...
Read
More
Thesis
Citius Pharmaceuticals just received FDA approval for their new immunotherapy treatment, LYMPHIR. This approval could lead to significant revenue growth and investor interest, making it a strong long-term investment.
Go back
Tendies
@tendies
Bought CTXR
Shares
up 1104%
At 0.82, Exited 9.88
With the recent FDA approval for their immunotherapy treatment LYMPHIR, I believe CTXR has significant growth potential. This kind of approval can dri...
Read
More
Thesis
With the recent FDA approval for their immunotherapy treatment LYMPHIR, I believe CTXR has significant growth potential. This kind of approval can drive long-term value and solidify their presence in the pharmaceutical market.
Go back
Day
@day_king
Bought UPST
Shares
up 115%
At 32.98, Now 70.94
Upstart Holdings skyrocketed by over 39% due to strong earnings, signaling potential for significant continued growth. This momentum could present a p...
Read
More
Thesis
Upstart Holdings skyrocketed by over 39% due to strong earnings, signaling potential for significant continued growth. This momentum could present a profitable swing trade opportunity.
Go back
Tendies
@tendies
Bought PSNY
Shares
up 82.03%
At 0.68, Exited 1.23
With Geely's backing and Polestar's impressive sales growth and upcoming models, I believe Polestar is poised to capture a significant share of the ex...
Read
More
Thesis
With Geely's backing and Polestar's impressive sales growth and upcoming models, I believe Polestar is poised to capture a significant share of the expanding EV market, making PSNY a strong long-term investment.
Go back
Tendies
@tendies
Bought RR
Shares
up 67.76%
At 0.54, Exited 0.91
Despite the sudden price drop, there haven't been any major news or fundamentals shifts to justify this decline, making it a potential rebound opportu...
Read
More
Thesis
Despite the sudden price drop, there haven't been any major news or fundamentals shifts to justify this decline, making it a potential rebound opportunity. I'll be buying shares, expecting the stock to recover as the market stabilizes.
Go back
Tendies
@tendies
Bought IXHL
Shares
up 47.0%
At 2.0, Exited 2.94
With IXHL's late stage trials on both sleep apnea and rheumatoid arthritis, along with a strong patent portfolio and market cap of only $30M, I'm bett...
Read
More
Thesis
With IXHL's late stage trials on both sleep apnea and rheumatoid arthritis, along with a strong patent portfolio and market cap of only $30M, I'm betting on it as a potential 10-bagger if the phase 2b/3 readouts are positive.
Go back
Stock
@stockmoe
Bought NVDA
Shares
up 38.65%
At 104.8, Exited 145.3
NVIDIA is in the Goldilocks zone around $101, which represents a great buying opportunity. Despite recent drops due to the carry trade, it’s a strong ...
Read
More
Thesis
NVIDIA is in the Goldilocks zone around $101, which represents a great buying opportunity. Despite recent drops due to the carry trade, it’s a strong buy for those who believe in the stock’s long-term potential.
Go back
Tendies
@tendies
Bought NRXBF
Shares
up 21.26%
At 0.42, Exited 0.51
The approval of a Japanese patent, alongside existing US and Russia patents, and the upcoming presentation at the Emerging Growth Conference, signals ...
Read
More
Thesis
The approval of a Japanese patent, alongside existing US and Russia patents, and the upcoming presentation at the Emerging Growth Conference, signals potential growth for NRXBF. The Golden Cross technical indicator further supports a bullish outlook, making NRXBF a promising long-term investment.
Go back
Tendies
@tendies
Bought RR
Shares
up 19.09%
At 0.54, Exited 0.64
Despite the sudden price drop, the fundamentals of Richtech Robotics (RR) remain solid with no significant news to justify such a sharp decline. This ...
Read
More
Thesis
Despite the sudden price drop, the fundamentals of Richtech Robotics (RR) remain solid with no significant news to justify such a sharp decline. This looks like an overreaction, making it a good opportunity to buy in low for long-term potential.
Go back
Tendies
@tendies
Bought ASTS
Shares
up 16.24%
At 21.3, Exited 24.76
With the FCC's approval of their satellite launch and additional investments from major partners like AT&T and Google, ASTS is poised for growth. This...
Read
More
Thesis
With the FCC's approval of their satellite launch and additional investments from major partners like AT&T and Google, ASTS is poised for growth. This stock has strong potential, and I believe it’s a great long-term investment opportunity.
Go back
Tendies
@tendies
Bought CTM
Shares
up 14.79%
At 0.14, Exited 0.17
With Canterra's recent strategic acquisition and promising copper samples from the Victoria project, there is significant growth potential here. The c...
Read
More
Thesis
With Canterra's recent strategic acquisition and promising copper samples from the Victoria project, there is significant growth potential here. The company's strategic location and expanded footprint further indicate a strong future performance. I'm going long on CTM for a solid swing trade.
Go back
Stock
@stockmoe
Bought QQQ
Shares
up 14.01%
At 450.7, Exited 513.8
Given the historical performance of QQQ and the strong fundamentals over the last 30 years, I believe buying QQQ will yield steady annual returns of o...
Read
More
Thesis
Given the historical performance of QQQ and the strong fundamentals over the last 30 years, I believe buying QQQ will yield steady annual returns of over 14%. This long-term investment strategy is suitable for those looking to DCA and hold for decades.
Go back
Tendies
@tendies
Bought GSAT
Shares
up 13.68%
At 1.17, Exited 1.33
GSAT is trading under $1.20 and being chosen by Apple for their LEO network. As more users upgrade to the latest iPhone, GSAT's usage will grow, makin...
Read
More
Thesis
GSAT is trading under $1.20 and being chosen by Apple for their LEO network. As more users upgrade to the latest iPhone, GSAT's usage will grow, making it a good long-term investment opportunity.
Go back
Day
@day_king
Bought ECVT
Shares
up 6.82%
At 7.48, Now 7.99
Based on my daily insider trading analysis, I traded ECVT today in biotech and made a nice profit from its early day movement.
Thesis
Based on my daily insider trading analysis, I traded ECVT today in biotech and made a nice profit from its early day movement.
Go back
Tendies
@tendies
Bought OCGN
Shares
up 2.38%
At 1.26, Exited 1.29
With the recent FDA approval for the expanded access program (EAP) for their breakthrough gene therapy, OCU400, and ongoing positive clinical trials, ...
Read
More
Thesis
With the recent FDA approval for the expanded access program (EAP) for their breakthrough gene therapy, OCU400, and ongoing positive clinical trials, I see a strong potential for OCGN to surge. The stock has hit $2 multiple times and positive news keeps rolling in.
Go back
Tendies
@tendies
Bought NRX
Shares
0.0%
At 0.14, Exited 0.14
Nurexone Biologics is on course for significant growth in regenerative medicine, with promising results from preclinical trials and expanding market p...
Read
More
Thesis
Nurexone Biologics is on course for significant growth in regenerative medicine, with promising results from preclinical trials and expanding market potential. The recent bullish Golden Cross signal suggests a positive trend change in the stock price.
Go back
Tendies
@tendies
Bought BEEM
Shares
down -3.2%
At 5.31, Exited 5.14
With Beam Global expanding into Europe and the upcoming earnings report on August 13, I believe that the stock is set to rise due to the positive impa...
Read
More
Thesis
With Beam Global expanding into Europe and the upcoming earnings report on August 13, I believe that the stock is set to rise due to the positive impact of recent contracts and the company's compelling solutions for EV charging problems.
Go back
Scalp
@scalpgan...
Bought WW
Shares
down -7.07%
At 0.99, Exited 0.92
Based on significant insider trading filings and the recent 35% increase in stock price, I believe this lower volume, lower market cap stock is poised...
Read
More
Thesis
Based on significant insider trading filings and the recent 35% increase in stock price, I believe this lower volume, lower market cap stock is poised for another short-term uptick. Insider trades often act as strong positive catalysts.
Go back
Tendies
@tendies
Bought RNXT
Shares
down -7.83%
At 1.15, Exited 1.06
With the positive early-stage clinical data showing significant improvement in overall survival for LAPC patients using the TAMP platform, RNXT is set...
Read
More
Thesis
With the positive early-stage clinical data showing significant improvement in overall survival for LAPC patients using the TAMP platform, RNXT is set to benefit as its Phase III trial progresses, making it a good swing trade opportunity.
Go back
Tendies
@tendies
Bought BLGO
Shares
down -9.71%
At 0.26, Exited 0.23
With BioLargo achieving a record quarterly revenue of $5 million and a significant 247% increase compared to last year’s second quarter, I believe the...
Read
More
Thesis
With BioLargo achieving a record quarterly revenue of $5 million and a significant 247% increase compared to last year’s second quarter, I believe their stock will continue to rise as they advance the commercialization of their cleantech products.
Go back
Tendies
@tendies
Bought SBS
Shares
down -9.78%
At 17.69, Exited 15.96
With the ongoing privatization and substantial government contracts aimed at expanding water coverage, SBS is poised for long-term growth. The expecte...
Read
More
Thesis
With the ongoing privatization and substantial government contracts aimed at expanding water coverage, SBS is poised for long-term growth. The expected efficiency improvements and revenue increase make it a compelling investment opportunity.
Go back
Tendies
@tendies
Bought ABVE
Shares
down -10.56%
At 1.42, Exited 1.27
With the recent business combination and Nasdaq listing, I believe Above Food is in a strong position to capitalize on the growing demand for sustaina...
Read
More
Thesis
With the recent business combination and Nasdaq listing, I believe Above Food is in a strong position to capitalize on the growing demand for sustainable food options, making it a great opportunity for long-term growth.
Go back
Tendies
@tendies
Bought PRSO
Shares
down -13.85%
At 1.3, Exited 1.12
Peraso Inc. is set to benefit significantly from the IEEE's new Wi-Fi standards which integrate mmWave technology. This will likely drive their stock ...
Read
More
Thesis
Peraso Inc. is set to benefit significantly from the IEEE's new Wi-Fi standards which integrate mmWave technology. This will likely drive their stock higher as they capitalize on new market opportunities and future demand for faster and more efficient Wi-Fi technology.
Go back
Tendies
@tendies
Bought KULR
Shares
down -21.98%
At 0.28, Exited 0.22
Given the upcoming Q2 earnings release with strong contract updates, I believe KULR is set to rise significantly. The new and recurring contracts sugg...
Read
More
Thesis
Given the upcoming Q2 earnings release with strong contract updates, I believe KULR is set to rise significantly. The new and recurring contracts suggest a robust financial performance, making it a solid swing trade opportunity.
Go back
Tendies
@tendies
Bought LPSN
Shares
down -28.24%
At 1.24, Exited 0.89
I've been analyzing LivePerson ($LPSN) and decided to invest due to faith in the new team's potential and positive product feedback. I believe it can ...
Read
More
Thesis
I've been analyzing LivePerson ($LPSN) and decided to invest due to faith in the new team's potential and positive product feedback. I believe it can reach $20 in the next two years.
Go back
Tendies
@tendies
Bought LPSN
Shares
down -28.24%
At 1.24, Exited 0.89
The partnership with Sycurio significantly strengthens LivePerson's position by offering secure payment solutions integrated with conversational AI. T...
Read
More
Thesis
The partnership with Sycurio significantly strengthens LivePerson's position by offering secure payment solutions integrated with conversational AI. This positions LPSN for future growth by expanding its market reach and enhancing its competitive edge, making it a solid long-term investment.
Go back
Day
@day_king
Shorted NVDA
Shares
down -36.8%
At 97.64, Now 133.57
I shorted Nvidia after a significant jump in afterhours, leveraging the volatility for over 10% gains in just half an hour.
Thesis
I shorted Nvidia after a significant jump in afterhours, leveraging the volatility for over 10% gains in just half an hour.
Go back
Tendies
@tendies
Bought ABVE
Shares
down -51.76%
At 1.42, Exited 0.69
Above Food's strategic acquisition of The Redwood Group's Specialty Crop Food Ingredients Division significantly expands its market footprint in the h...
Read
More
Thesis
Above Food's strategic acquisition of The Redwood Group's Specialty Crop Food Ingredients Division significantly expands its market footprint in the high-growth pet food sector and enhances its supply chain capabilities, making it a promising long-term investment opportunity.
Go back
